MRRI Scientists and Collaborators Receive Chernowitz Medical Research Foundation Award
The Moss Rehabilitation Research Institute (MRRI) has been awarded funding to further develop treatments for patients who have experienced a stroke. Over $400,000 from The Chernowitz Medical Research Foundation will support this MRRI-led study and conducted in collaboration with the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, Harvard Medical School, and Massachusetts Institute of Technology.
Led by Principal Investigator, Dylan Edwards, PhD, Director of MRRI and Director of the Human Motor Recovery Laboratory, the study titled “Precision Targeting for Transcranial Magnetic Stimulation (TMS) Treatment in Stroke Patients” will validate advanced computational TMS mapping methods for clinical and research applications including depression, neurosurgery, and stroke. Co-Principal Investigators include Shailesh Kantak, PhD, Institute Scientist and Director of the Neuroplasticity and Motor Behavior Laboratory at MRRI and Aapo Nummenmaa, PhD, Assistant Professor of Radiology at Harvard Medical School, Assistant in Neuroscience at Massachusetts General Hospital, and Director of the TMS Core at the Martinos Center. Co-Investigators are Sergey N. Makarov, PhD, and Mohammad Daneshzand, PhD.
George and Edith Chernowitz were pioneers in the development of quality control in scientific and industrial applications. Together, they created the The Chernowitz Medical Research Foundation as their legacy to enhance human health and well-being by supporting innovative research in the areas of circulatory disorders and mental health.
